Envoy MedicalCOCH +15.77%24 Market Cap is $60.00 Mil as of Jul. 01, 2026. GuruFocus rates COCH with a GF Score™ of 24/100 and a GF Value™ of $1.14 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 867 Medical Devices & Instruments companies, Envoy Medical ranks worse than 61.82% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Envoy Medical's share price for the quarter that ended in Mar. 2026 was $0.6651. Envoy Medical's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 76.88 Mil. Therefore, Envoy Medical's market cap for the quarter that ended in Mar. 2026 was $51.13 Mil.
Envoy Medical's quarterly market cap
increased
from Sep. 2025 ($18.47 Mil) to Dec. 2025 ($19.13 Mil) and
increased
from Dec. 2025 ($19.13 Mil) to Mar. 2026 ($51.13 Mil).
Envoy Medical's annual market cap
declined
from Dec. 2023 ($35.49 Mil) to Dec. 2024 ($30.50 Mil) and
declined
from Dec. 2024 ($30.50 Mil) to Dec. 2025 ($19.13 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Envoy Medical's Enterprise Value for Today is $36.64 Mil.
Envoy Medical (NAS:COCH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Envoy Medical Market Cap Related Terms
Envoy Medical Market Cap Historical Data
* Premium members only.
The historical data trend for Envoy Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Envoy Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envoy Medical Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Envoy Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Envoy Medical's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Envoy Medical (COCH) has a Market Cap of $60.00 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Envoy Medical and its competitors. According to the industry distribution chart, Envoy Medical ranks #536 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 61.8%.
Is Envoy Medical's Market Cap too high?
Envoy Medical's current Market Cap is $60.00 Mil. The Medical Devices & Instruments industry median Market Cap is 120.18. Envoy Medical's value of $60.00 Mil is 50.1% below this industry median. Based on the distribution chart, Envoy Medical ranks #536 out of 867 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Envoy Medical has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Envoy Medical's Market Cap compare to SRTS and QTI?
According to the Medical Devices & Instruments industry distribution chart, Envoy Medical ranks #536 out of 867 companies for Market Cap. This places Envoy Medical in the lower half of its industry. The industry median Market Cap is 120.18. Envoy Medical's value of $60.00 Mil is 50.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.18, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Envoy Medical's current Market Cap of $60.00 Mil is 50.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Envoy Medical and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Envoy Medical's current Market Cap is $60.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envoy Medical stock overvalued right now?
Based on GuruFocus' analysis, Envoy Medical (COCH) is currently considered Possible Value Trap. The stock's GF Value™ is $1.14, compared to a current price of $0.78 — trading 31.7% below its estimated fair value. The current Market Cap is $60.00 Mil and 50.1% below the Medical Devices & Instruments industry median of 120.18. Envoy Medical's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Envoy Medical (COCH), the current Market Cap is $60.00 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envoy Medical (COCH) Overvalued in 2026?
Based on GuruFocus' analysis, Envoy Medical stock appears to be undervalued.
The current stock price of $0.78 is trading 31.7% below its estimated GF Value™ of $1.14.
GuruFocus considers Envoy Medical to be Possible Value Trap.
Key valuation signals for COCH:
Market Cap: $60.00 Mil
GF Value™: $1.14 vs. price of $0.78 (31.7% below fair value)
Industry Position: 50.1% below the Medical Devices & Instruments median (#536 of 867)
No single metric tells the full story. See the COCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
24GF Score
Get the complete analysis for COCH
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COCH has been successfully added to your 
